The roll out of more effective and affordable screening programes alongside advancements in treatment options have resulted in declining death rates over the last few decades. Despite this, breast cancer remains the most common type of cancer in woman globally with approximately 1.5 million new cases diagnosed each year.
In this InFocus we will investigate the latest research, asks the leading experts the most pressing questions and explore breaking news.
Listen to this podcast to discover more about the UNICANCER-NeoPAL study of letrozole and palbociclib in luminal cancer, data from which was presented at this years 2017 ESMO Congress (8–12th September, Madrid, Spain).
In an exclusive interview, Greg Hannon from Cancer Research UK Cambridge Institute (UK), speaks to Oncology Central about his Grand Challenge project to create a virtual reality tumor.
Read the news piece here